Hence, the objective of the present study was to investigate the prognostic value of FOXP4-AS1 expression in human ovarian serous cystadenocarcinoma (OVs) based on data obtained from The Cancer Genome Atlas (TCGA). This evidence concerns the gene FOXP4 and ovarian serous cystadenocarcinoma.